95 related articles for article (PubMed ID: 10468288)
1. Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase.
Evrard A; Cuq P; Ciccolini J; Vian L; Cano JP
Br J Cancer; 1999 Aug; 80(11):1726-33. PubMed ID: 10468288
[TBL] [Abstract][Full Text] [Related]
2. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
Ishikawa T; Tanaka Y; Ishitsuka H; Ohkawa T
Jpn J Cancer Res; 1989 Jun; 80(6):583-91. PubMed ID: 2527217
[TBL] [Abstract][Full Text] [Related]
3. Efficient Expression of Soluble Recombinant Protein Fused with Core-Streptavidin in Bacterial Strain with T7 Expression System.
Tarar A; Alyami EM; Peng CA
Methods Protoc; 2020 Dec; 3(4):. PubMed ID: 33271819
[TBL] [Abstract][Full Text] [Related]
4. Mucinous Adenocarcinoma of the Rectum: A Whole Genome Sequencing Study.
Reynolds IS; Thomas V; O'Connell E; Fichtner M; McNamara DA; Kay EW; Prehn JHM; Burke JP; Furney SJ
Front Oncol; 2020; 10():1682. PubMed ID: 32984045
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil Conversion Pathway Mutations in Gastric Cancer.
Biagioni A; Staderini F; Peri S; Versienti G; Schiavone N; Cianchi F; Papucci L; Magnelli L
Biology (Basel); 2020 Sep; 9(9):. PubMed ID: 32887417
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities.
Sedighi M; Zahedi Bialvaei A; Hamblin MR; Ohadi E; Asadi A; Halajzadeh M; Lohrasbi V; Mohammadzadeh N; Amiriani T; Krutova M; Amini A; Kouhsari E
Cancer Med; 2019 Jun; 8(6):3167-3181. PubMed ID: 30950210
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells.
Mori R; Yoshida K; Futamura M; Suetsugu T; Shizu K; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K
Gastric Cancer; 2019 May; 22(3):497-505. PubMed ID: 30276573
[TBL] [Abstract][Full Text] [Related]
8. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
Banales JM; Cardinale V; Carpino G; Marzioni M; Andersen JB; Invernizzi P; Lind GE; Folseraas T; Forbes SJ; Fouassier L; Geier A; Calvisi DF; Mertens JC; Trauner M; Benedetti A; Maroni L; Vaquero J; Macias RI; Raggi C; Perugorria MJ; Gaudio E; Boberg KM; Marin JJ; Alvaro D
Nat Rev Gastroenterol Hepatol; 2016 May; 13(5):261-80. PubMed ID: 27095655
[TBL] [Abstract][Full Text] [Related]
9. The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy.
Marin JJ; Monte MJ; Blazquez AG; Macias RI; Serrano MA; Briz O
Acta Pharmacol Sin; 2014 Jan; 35(1):1-10. PubMed ID: 24317012
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity.
Fanciullino R; Mollard S; Giacometti S; Berda-Haddad Y; Chefrour M; Aubert C; Iliadis A; Ciccolini J
Pharm Res; 2013 May; 30(5):1281-90. PubMed ID: 23386105
[TBL] [Abstract][Full Text] [Related]
11. High expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers.
Umemura S; Shirane M; Takekoshi S; Tokuda Y; Mori K; Osamura RY
Oncol Lett; 2010 Mar; 1(2):261-266. PubMed ID: 22966291
[TBL] [Abstract][Full Text] [Related]
12. Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy.
Watson RG; Muhale F; Thorne LB; Yu J; O'Neil BH; Hoskins JM; Meyers MO; Deal AM; Ibrahim JG; Hudson ML; Walko CM; McLeod HL; Auman JT
Eur J Cancer; 2010 Dec; 46(18):3358-64. PubMed ID: 20727737
[TBL] [Abstract][Full Text] [Related]
13. Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation.
Raynal C; Pascussi JM; Leguelinel G; Breuker C; Kantar J; Lallemant B; Poujol S; Bonnans C; Joubert D; Hollande F; Lumbroso S; Brouillet JP; Evrard A
Mol Cancer; 2010 Mar; 9():46. PubMed ID: 20196838
[TBL] [Abstract][Full Text] [Related]
14. Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer.
Nieto Y; Aramendía JM; Espinós J; De la Cruz S; Fernández-Hidalgo O; Santisteban M; Arbea L; Aristu J; Martínez-Monge R; Moreno M; Pina L; Sola J; Zornoza G; Regueira FM
Cancer Chemother Pharmacol; 2010 Feb; 65(3):457-65. PubMed ID: 19526361
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.
Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J
Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948
[TBL] [Abstract][Full Text] [Related]
16. Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model.
Wang W; Tai CK; Kershaw AD; Solly SK; Klatzmann D; Kasahara N; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E25. PubMed ID: 16709031
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of GSTP1 and MRP1 in melanoma drug resistance.
Depeille P; Cuq P; Passagne I; Evrard A; Vian L
Br J Cancer; 2005 Jul; 93(2):216-23. PubMed ID: 15999103
[TBL] [Abstract][Full Text] [Related]
18. 5-Fluorouracil concentration in blood, liver and tumor tissues and apoptosis of tumor cells after preoperative oral 5'-deoxy-5-fluorouridine in patients with hepatocellular carcinoma.
Zheng JF; Wang HD
World J Gastroenterol; 2005 Jul; 11(25):3944-7. PubMed ID: 15991299
[TBL] [Abstract][Full Text] [Related]
19. Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration.
Zhou J; Xiao YS; Tang ZY; Fan J; Wu ZQ; Zhao Y; Xue Q; Shen ZZ; Liu YK; Ye SL
J Cancer Res Clin Oncol; 2005 Aug; 131(8):547-51. PubMed ID: 15864645
[TBL] [Abstract][Full Text] [Related]
20. Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer.
Toi M; Bando H; Horiguchi S; Takada M; Kataoka A; Ueno T; Saji S; Muta M; Funata N; Ohno S
Br J Cancer; 2004 Jun; 90(12):2338-43. PubMed ID: 15150550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
